Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review

• Published in: JBMR plus 2023-05, Vol.7 (5), p.e10728-n/a
• Main Authors: Munns, Craig F, Maguire, Edward P, Williams, Angela, Wood, Sue, Biggin, Andrew
• Format: Article
• Language: English
• Subjects: Birth defects; Bone diseases; Case reports; Clinical medicine; Congenital diseases; Cranial sutures; CRANIOSYNOSTOSIS; Diagnosis; Fetuses; FIBROBLAST GROWTH FACTOR 23; Fibroblasts; Growth factors; Hypophosphatemia; Literature reviews; Metabolic disorders; Metabolism; Mineralization; Mutation; Patients; PHOSPHATE; Quality of life; Review; Rickets; SCAPHOCEPHALY; Sutures; Transcription factors; Vitamin D; X‐LINKED HYPOPHOSPHATEMIA
• ISSN: 2473-4039; 2473-4039
• DOI: 10.1002/jbm4.10728

ABSTRACT Craniosynostosis is a rare condition of skull development, manifesting during fetal and early infant development, and is usually congenital. Craniosynostosis secondary to metabolic disorders, such as X‐linked hypophosphatemia (XLH), is less common and is typically diagnosed later than congenital craniosynostosis. XLH is a rare, progressive, and lifelong hereditary phosphate‐wasting disorder characterized by loss of function of the phosphate‐regulating endopeptidase homologue, X‐linked gene, which is associated with premature fusion of cranial sutures due to abnormal phosphate metabolism (hypophosphatemia) and altered bone mineralization or elevated levels of fibroblast growth factor 23. This targeted literature review of 38 articles seeks to provide an overview of craniosynostosis in individuals with XLH. The objectives of this review are to increase awareness of the prevalence, presentation, and diagnosis of craniosynostosis in XLH; examine the spectrum of craniosynostosis severity in XLH; discuss the management of craniosynostosis in those with XLH; recognize the complications for patients with XLH; and identify what is known about the burden of craniosynostosis for individuals with XLH. The presentation of craniosynostosis in individuals with XLH tends to manifest slightly later than congenital craniosynostosis and can vary in severity and appearance, making diagnosis difficult and resulting in inconsistent clinical outcomes. Consequently, craniosynostosis in patients with XLH is an underreported and potentially underrecognized condition. There have been no studies investigating the effects of craniosynostosis on the quality of life of people with XLH. Despite a growing awareness among researchers and experienced clinicians, there are still improvements to be made in general awareness and timely diagnosis of craniosynostosis in XLH. The XLH community would benefit from further study into the prevalence of craniosynostosis, the effect of XLH medical therapy on the development of craniosynostosis, and the effects of craniosynostosis on quality of life. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. XLH is associated with an increased risk of craniosynostosis. Common presenting features are sagittal suture fusion, scaphocephaly, and altered head size/circumference. Frequent complications are elevated intracranial pressure, headaches, Chiari malformation type 1, papilled